Meagan Mayo, Carla McWilliams
Background: Hospital-acquired infections (HAI) remain a leading source of preventable morbidity and mortality, and excess health-care expenditure in intensive care units (ICU). Despite substantial advances in infection prevention, central line—associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated events, ventilator-associated pneumonia, and Clostridioides difficile infections continue to cause significant harm. The Centers for Medicare and Medicaid Services (CMS), through the National Healthcare Safety Network, mandates surveillance, and public reporting, linking infection rates to hospital reimbursement and penalties under the Hospital-Acquired Condition Reduction Program. This has intensified pressure on healthcare systems to balance financial accountability and reporting with evidence-based, patient-centered care. These reported patient safety indications impact overall performance and system reputation with raters and rankers. This article reviews the current evidence and guideline-based practices for preventing ICU-related infections, with attention to the nuances of reporting requirements, antimicrobial and diagnostic stewardship, and emerging antimicrobial resistance. In addition, it explores the financial and ethical tensions between administrative reporting requirements and bedside clinical decision-making. We sought to underscore the importance of collaboration among infection prevention specialists, intensivists, and infectious disease physicians while providing the highest quality of bedside patient care. Methods: We conducted a narrative review of current evidence and guideline-based practices for preventing ICU-related infections. Particular attention was given to reporting requirements, antimicrobial and diagnostic stewardship strategies, and the growing challenge of antimicrobial resistance. We also examined the financial and ethical tensions that arise between administrative reporting obligations and bedside clinical decision-making. Results: Evidence-based infection prevention strategies including standardized device-care bundles, antimicrobial stewardship, diagnostic stewardship, and multidisciplinary collaboration remain central to reducing ICU-related HAIs. However, regulatory reporting structures and reimbursement-linked metrics may at times create competing priorities between documentation requirements and individualized patient care. Emerging antimicrobial resistance further complicates efforts and underscores the need for coordinated stewardship activities. Conclusion: Reducing ICU-related healthcare associated infections requires collaboration amongst infection prevention specialists, intensivists, and infectious disease physicians. Healthcare systems must strive to align regulatory requirements with high-quality, patient-centered bedside care. A balanced approach that integrates evidence-based prevention, stewardship principles, and transparent reporting is essential to improving outcomes while maintaining financial and ethical accountability.